Insider filing · SRRK
Srinivas Akkaraju
Director
profile →
Scholar Rock Holding Corporation
SRRK · Healthcare · 62 filings in 24 months
ticker →
Srinivas Akkaraju sold $34.4M of Scholar Rock Holding (SRRK)
Executed Oct 7 2024, disclosed Oct 7 2024, the same day.
Value, as filed
$34.4M
1,175,713 sh across 3 lots
Executed
Oct 7 2024
the trade date, as filed
Disclosed
Oct 7 2024
0 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
SASrinivas Akkaraju (Director) filed 12 Form 4 reports in the trailing twelve months (12 purchases, 1 sale, 2 filed past the two-business-day deadline), most often in Alumis Inc. (ALMS). Across 11 priced purchase filings, the average 21-session return was +37.1% from execution and +27.8% from disclosure (delay-adjusted; derived). The largest single filing was $18.8M of SRRK (500,439 sh across 6 lots, as filed), executed Oct 3 2025.
The name
SRRKHealthcare · Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on improving the lives of children and adults with spinal muscular a…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Srinivas Akkaraju in SRRK
SRRKPURCHASE
Scholar Rock Holding Corporation
$1.2M29,599 sh across 3 lots
Exec Oct 7 2025
Filed Dec 16 2025 · 9:07 PM ET † SRRKPURCHASE Scholar Rock Holding Corporation $18.8M
500,439 sh across 6 lots
Exec Oct 3 2025
Filed Oct 7 2025 · 8:59 PM ET